stockminded.com
  • StockMinded Newsletter!
  • Knowledge
    • Stocks
    • ETFs
    • Crypto
    • Bonds
No Result
View All Result
No Result
View All Result
stockminded.com
No Result
View All Result
Home NEWS

Intel Q3 2025: Revenue Beat, Non-GAAP EPS Surprise, and a Cautious Q4 Guide

by Anna Richter
17. November 2025
in NEWS
Intel Q3 2025: Revenue Beat, Non-GAAP EPS Surprise, and a Cautious Q4 Guide

Table of Contents

Toggle
  • Quick Take
  • Headline Numbers (Q3 FY2025)
  • Segment Check: Where Growth Came From
  • Gross Margin & Costs: The Bridge
  • Strategic Notes
  • Stock Reaction: What’s in the Tape
  • What to Watch Next
  • Bottom Line
  • FAQ
  • Disclaimer

Quick Take

Intel delivered a clean top-line beat and a meaningful non-GAAP EPS surprise, powered by steadier PC demand and disciplined opex. Guidance for Q4 lands in line to slightly cautious, reflecting portfolio changes and a measured view on data center spending into year-end.


Headline Numbers (Q3 FY2025)

  • Revenue: $13.7B (+3% YoY).
  • Gross margin: ~38% GAAP / ~40% non-GAAP (strong improvement YoY).
  • Diluted EPS: $0.90 GAAP (benefit from one-offs); $0.23 non-GAAP.
  • Cash from operations: ~$2.5B.
  • Capex (gross): ~$3.0B; partner contributions in the quarter helped fund the build-out.
  • Workforce: continued right-sizing vs. last year as the transformation progresses.

Q4 2025 Outlook (midpoint):

  • Revenue: $12.8–$13.8B.
  • Gross margin: ~34.5% GAAP / ~36.5% non-GAAP.
  • Non-GAAP EPS: ~$0.08.
    (Note: outlook excludes Altera after majority deconsolidation in Q3.)

Segment Check: Where Growth Came From

  • Client Computing Group (CCG): $8.5B, +5% YoY. AI-PC refresh and commercial upgrades supported units and mix.
  • Data Center & AI (DCAI): $4.1B, −1% YoY. Hyperscaler digestion and project timing muted growth, though host CPUs for AI servers remained a relative bright spot.
  • Intel Foundry (IFS): $4.2B, −2% YoY (before intersegment eliminations). Run-rate reflects internal ramp cadence and external programs in flight.
  • All other: ~$1.0B, +3% YoY.

Intersegment eliminations of roughly $4.2B reconcile to total reported revenue of $13.7B.


Gross Margin & Costs: The Bridge

  • Mix & cost control lifted margin sharply vs. last year.
  • R&D/MG&A declined double-digits YoY on restructuring and tighter spending, cushioning the impact of uneven data center demand.
  • One-offs inflated GAAP EPS; non-GAAP better reflects underlying progress.

Strategic Notes

  • Portfolio moves: Intel completed the deconsolidation of Altera (51% stake sold) in September, simplifying reporting and sharpening focus on core roadmaps and foundry strategy.
  • PC platform cycle: The AI PC refresh is moving from concept to deployment, supporting CCG momentum into 2026.
  • Foundry execution: Capacity investments and partner funding continue to underwrite the leading-edge roadmap, with customer traction a key proof point over the next 12 months.

Stock Reaction: What’s in the Tape

INTC traded actively after the print as investors balanced a better-than-feared quarter with a prudent Q4 guide. Factors in play:

  1. Beat quality: Revenue and non-GAAP EPS clearly ahead; margin trajectory encouraging.
  2. Guide optics: Q4 range is reasonable but leaves little room for macro hiccups.
  3. Positioning: After a pre-earnings run, the setup favored show-me follow-through on margin and orders.

What to Watch Next

  1. Q4 execution vs. guide: Delivery on gross margin and opex discipline as seasonal PC strength normalizes.
  2. DCAI momentum: Signs that cloud digestion fades; visibility on next-gen CPUs and AI-adjacent attach.
  3. AI PC adoption: Enterprise pilots, refresh budgets, and OEM commentary on attach rates.
  4. Foundry milestones: External customer announcements, 18A readiness, and wafer-starts cadence.
  5. Cash & capex: Partner contributions, incentive inflows, and the pace of capex tied to leading-edge capacity.

Bottom Line

Intel’s Q3 shows operational progress: a top-line beat, non-GAAP EPS upside, and better margins—tempered by a measured Q4. If CCG holds, DCAI stabilizes, and foundry milestones land on time, the 2026 bridge (margin + mix + AI PC cycle + foundry credibility) becomes more believable. For now, it’s a constructive update with a show-me fourth quarter ahead.

Related articles

Moderna Stock Jumps 8% Again – but This Rally Is Becoming a High-Stakes Bet on Cancer

Moderna Stock Jumps 8% Again – but This Rally Is Becoming a High-Stakes Bet on Cancer

11. September 2026
Microsoft (MSFT): Fresh Drivers Moving the Stock Now

Microsoft Stock Faces a 38-Gigawatt AI Bet as Data Center Buildout

11. September 2026
Micron’s Re-Rating: How Rising DRAM Prices and an HBM Supercycle Could Power MU Through 2026

Micron Stock Faces a New Cost as Taiwan Engineers Get Huge Bonuses

11. September 2026
Stock Market Basics – The Complete Beginner’s Guide to Trading and Investing

Oracle Stock Jumps as $90 Billion Revenue Target Turns Its AI Gamble Into a Much Bigger Story

11. September 2026
Adobe Stock Whipsaws After Another Earnings Beat in Q3

Adobe Stock Whipsaws After Another Earnings Beat in Q3

10. September 2026

FAQ

Did Intel beat expectations?
Yes. Revenue and non-GAAP EPS came in ahead of consensus, with gross margin improving meaningfully year over year.

What drove the beat?
A firmer PC cycle, cost discipline, and mix improved non-GAAP profitability despite uneven data center demand.

Why is Q4 guidance cautious?
Management signaled a balanced view on year-end demand and program timing, with portfolio changes (e.g., Altera) also affecting comparability.

Is gross margin recovery real?
Trend-wise, yes—mix and cost actions helped. Sustaining it will depend on DCAI reacceleration and ongoing cost execution.

What’s the single most important proof point for 2026?
Customer-validated foundry milestones (nodes, PDKs, tape-outs) alongside AI PC adoption rate and steadier data center demand.


Disclaimer

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any security. Investing involves risk, including the possible loss of principal. Always conduct your own research and consider consulting a licensed financial advisor.

Related Posts

Moderna Stock Jumps 8% Again – but This Rally Is Becoming a High-Stakes Bet on Cancer

Moderna Stock Jumps 8% Again – but This Rally Is Becoming a High-Stakes Bet on Cancer

11. September 2026

Moderna stock surged more than 8% on Friday, extending one of the wildest stretches in large-cap biotech after investors continued...

Microsoft (MSFT): Fresh Drivers Moving the Stock Now

Microsoft Stock Faces a 38-Gigawatt AI Bet as Data Center Buildout

11. September 2026

Microsoft stock has a new number for investors to digest: 38 gigawatts. Microsoft is reportedly planning to expand its global data-center...

Micron’s Re-Rating: How Rising DRAM Prices and an HBM Supercycle Could Power MU Through 2026

Micron Stock Faces a New Cost as Taiwan Engineers Get Huge Bonuses

11. September 2026

Micron stock is confronting an unusual new variable in its AI-fueled growth story: the company is handing out its richest...

Stock Market Basics – The Complete Beginner’s Guide to Trading and Investing

Oracle Stock Jumps as $90 Billion Revenue Target Turns Its AI Gamble Into a Much Bigger Story

11. September 2026

Oracle stock jumped after the software giant delivered a combination investors have been waiting to see: faster revenue growth, an...

Adobe Stock Whipsaws After Another Earnings Beat in Q3

Adobe Stock Whipsaws After Another Earnings Beat in Q3

10. September 2026

Adobe stock delivered one of the strangest reactions earnings season can produce Thursday: the software giant beat Wall Street expectations,...

Load More
  • Imprint
  • Terms and Conditions
  • Privacy Policies
  • Disclaimer
  • Contact
  • About us
  • Our Authors

© 2025 stockminded.com

No Result
View All Result
  • StockMinded Newsletter!
  • Knowledge
    • Stocks
    • ETFs
    • Crypto
    • Bonds

© 2025 stockminded.com